Cargando…
Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells
BACKGROUND: The pharmacologic modulatory effects of the antibiotic, tunicamycin (TM), on multidrug-resistant human UWOV2 ovarian cancer cells are reported. The UWOV2 cell line was derived from a cystadenocarcinoma in a patient refractory to combination chemotherapy with actinomycin D, vincristine (V...
Autores principales: | Hiss, Donavon C, Gabriels, Gary A, Folb, Peter I |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865531/ https://www.ncbi.nlm.nih.gov/pubmed/17439664 http://dx.doi.org/10.1186/1475-2867-7-5 |
Ejemplares similares
-
Optimizing Molecular-Targeted Therapies in Ovarian Cancer: The Renewed Surge of Interest in Ovarian Cancer Biomarkers and Cell Signaling Pathways
por: Hiss, Donavon
Publicado: (2012) -
Comprehensive analysis of LDHAP5 pseudogene expression and potential pathogenesis in ovarian serous cystadenocarcinoma
por: Lin, Shitong, et al.
Publicado: (2020) -
Melamine contamination in nutritional supplements - Is it an alarm bell for the general consumer, athletes, and ‘Weekend Warriors’?
por: Gabriels, Gary, et al.
Publicado: (2015) -
Comprehensive analysis of the expression of sodium/potassium-ATPase α subunits and prognosis of ovarian serous cystadenocarcinoma
por: Huang, Wei, et al.
Publicado: (2020) -
LPAR1 regulates the development of intratumoral heterogeneity in ovarian serous cystadenocarcinoma by activating the PI3K/AKT signaling pathway
por: Cui, Ran, et al.
Publicado: (2019)